多囊卵巢综合征与内皮健康、心血管风险及细胞衰老的关联
这项横断面研究纳入63例多囊卵巢综合征(PCOS)患者和130例非PCOS对照,评估内皮健康、心血管风险和细胞衰老。多变量校正模型显示PCOS与内皮功能障碍显著相关,但线粒体DNA、端粒长度、Framingham评分及代谢综合征与PCOS无显著关联。
要点
- PCOS与内皮功能障碍显著相关(分类变量OR 0.31,95%CI 0.10-0.97)。
- PCOS与线粒体DNA、端粒长度、Framingham评分无显著关联。
- PCOS与代谢综合征无显著关联(OR 1.29,95%CI 0.31-5.44)。
核心结论
- 研究提示PCOS患者较非PCOS患者存在内皮功能受损,但细胞衰老指标及Framingham评分所测心血管风险在两组间无差异。
研究设计与样本
- 横断面研究,纳入社区来源的PCOS患者63例及作为对照的正常卵巢衰老队列130例,评估时年龄≤45岁。
- 暴露为非侵入性EndoPAT反应性充血指数测定的内皮健康。
主要发现
- PCOS组平均年龄33.1岁(标准差4.7岁)显著低于非PCOS组40.8岁(标准差2.9岁)。
- 多变量校正模型中,PCOS与内皮功能障碍显著相关:分类变量OR 0.31(95%CI 0.10-0.97),连续变量PCOS系数-0.37(95%CI -0.69至-0.05)。
- PCOS与线粒体DNA无显著关联(PCOS系数-48.1,95%CI -175.0至78.9)。
- PCOS与端粒长度无显著关联(PCOS系数0.05,95%CI -0.05至0.15)。
- PCOS与Framingham评分无显著关联(PCOS系数0.002,95%CI -0.01至0.02),与代谢综合征无显著关联(OR 1.29,95%CI 0.31-5.44)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study measures of endothelial health, cardiovascular risk, and cellular aging between patients with polycystic ovary syndrome (PCOS) and a reproductive age normative cohort. DESIGN: Cross-sectional study. SUBJECTS: Community-based patients with PCOS and a normative ovarian aging cohort as controls, aged ≤45 years at the time of evaluation. EXPOSURE: Noninvasive measure of endothelial health measured by the EndoPAT reactive hyperemia index. MAIN OUTCOME MEASURES: Reactive hyperemia index as measure of endothelial health. The secondary outcomes included Framingham score, telomere length, and mitochondrial deoxyribonucleic acid copy number from leukocyte cells. RESULTS: Our cohort included 63 participants with PCOS and 130 non-PCOS participants. The mean age was significantly lower in the PCOS cohort (33.1; standard deviation, 4.7 years) than in the non-PCOS cohort (40.8; standard deviation, 2.9 years). In multivariable-adjusted models, we found that PCOS was significantly associated with endothelial dysfunction as both categorical (odds ratio for PCOS, 0.31; 95% confidence interval [CI], 0.10-0.97) and continuous (PCOS coefficient, -0.37; 95% CI, -0.69 to -0.05) outcomes. For secondary outcomes, PCOS status was not significantly associated with mitochondrial deoxyribonucleic acid (PCOS coefficient, -48.1; 95% CI, -175.0 to 78.9), telomere length (PCOS coefficient, 0.05; 95% CI, -0.05 to 0.15), Framingham score (PCOS coefficient, 0.002; 95% CI, -0.01 to 0.02), or metabolic syndrome (odds ratio for PCOS, 1.29; 95% CI, 0.31-5.44). CONCLUSION: Our findings suggest that patients with PCOS have impaired endothelial function compared with non-PCOS patients, although measures of cellular aging and cardiovascular risk as measured by the Framingham score did not differ between the cohorts.
引用
- Wang A, Corley J, Jaswa EG, et al. Association of polycystic ovary syndrome with endothelial health, cardiovascular risk, and cellular aging. Fertil Steril. 2025. PMID: 39818356. doi:10.1016/j.fertnstert.2025.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。